This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rowland, F. N. Articles by Kreutzer, D. L. Search for Related Content PubMed PubMed Citation Articles by Rowland, F. N. Articles by Kreutzer, D. L.

American Journal of Pathology, Vol 117, 418-428, Copyright © 1984 by American Society for Investigative Pathology

REGULAR ARTICLES

Fibrin-mediated vascular injury. Identification of fibrin peptides that mediate endothelial cell retraction

FN Rowland, MJ Donovan, PT Picciano, GD Wilner and DL Kreutzer

The deposition of fibrin, a ubiquitous component of acute and chronic inflammatory reactions, has been implicated by a number of recent studies as playing an active role in inflammation. In particular, fibrin deposition has been implicated in the development of tissue edema. As the "gateway" through which intravascular-to-extravascular movement of fluid, nutrients, and cells must pass, the vascular endothelial cells play a crucial regulatory role in this process. In support of this concept, recent studies in this laboratory have demonstrated that endothelial cells retract not only in the presence of fibrin but also in the presence of low molecular weight cleavage products of fibrinogen. It was further shown that this reaction was 1) specific for both vascular and corneal endothelial cells, 2) nontoxic, and 3) completely reversible. The present work examined the physiochemical nature of these endothelial-cell reactive factors. It was demonstrated by the use of enzymatically derived and synthetic fibrinogen peptides, that the active soluble fibrinogen-derived factor was associated with the amino-terminal end of the B chain of fibrinogen. The active factor has been tentatively identified as the B beta peptides, which is a primary plasmin cleavage product of fibrinogen and contains the thrombin-generated fibrinopeptide B. It is thus suggested that soluble, endothelial-cell-reactive peptides are released during both fibrinogenesis and fibrinolysis and, as such, modulate endothelial cell functions in vivo.

This article has been cited by other articles:

				H. Fujimoto, E. C. Gabazza, O. Taguchi, Y. Nishii, H. Nakahara, N. E. Bruno, C. N. D'Alessandro-Gabazza, M. Kasper, Y. Yano, M. Nagashima, et al. Thrombin-Activatable Fibrinolysis Inhibitor Deficiency Attenuates Bleomycin-Induced Lung Fibrosis Am. J. Pathol., April 1, 2006; 168(4): 1086 - 1096. [Abstract] [Full Text] [PDF]

				A. Sahni, S. K. Sahni, and C. W. Francis Endothelial Cell Activation by IL-1{beta} in the Presence of Fibrinogen Requires {alpha}V{beta}3 Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2222 - 2227. [Abstract] [Full Text] [PDF]

				A. Sahni, M. Guo, S. K. Sahni, and C. W. Francis Interleukin-1{beta} but not IL-1{alpha} binds to fibrinogen and fibrin and has enhanced activity in the bound form Blood, July 15, 2004; 104(2): 409 - 414. [Abstract] [Full Text] [PDF]

				F. M. Szaba and S. T. Smiley Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo Blood, February 1, 2002; 99(3): 1053 - 1059. [Abstract] [Full Text] [PDF]

				S. IDELL, A. P. MAZAR, P. BITTERMAN, S. MOHLA, and A. L. HARABIN Fibrin Turnover in Lung Inflammation and Neoplasia Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 578 - 584. [Full Text]

				G. E. Davis, K. J. Bayless, M. J. Davis, and G. A. Meininger Regulation of Tissue Injury Responses by the Exposure of Matricryptic Sites within Extracellular Matrix Molecules Am. J. Pathol., May 1, 2000; 156(5): 1489 - 1498. [Abstract] [Full Text] [PDF]

				A. F. Shorr and O. W. Hnatiuk Circulating D Dimer in Patients With Sarcoidosis Chest, April 1, 2000; 117(4): 1012 - 1016. [Abstract] [Full Text] [PDF]

				H. KOBAYASHI, E. C. GABAZZA, O. TAGUCHI, H. WADA, H. TAKEYA, J. NISHIOKA, H. YASUI, T. KOBAYASHI, O. HATAJI, K. SUZUKI, et al. Protein C Anticoagulant System in Patients with Interstitial Lung Disease Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1850 - 1854. [Abstract] [Full Text] [PDF]

				M. H. Kvist, M. U.K. Lehto, L. Jozsa, M. Jarvinen, and H. T. Kvist Chronic Achilles paratenonitis: An immunohistologic study of fibronectin and fibrinogen Am. J. Sports Med., December 1, 1988; 16(6): 616 - 623. [Abstract] [PDF]